|
OMIM |
Link |
Information gain |
01 |
|
fabry disease
|
[NCBI]
|
0.00108983
|
|
|
sandhoff disease
|
[NCBI]
|
0.000443845
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
0.000209551
|
|
|
NPC1
|
[NCBI]
|
0.000204036
|
|
|
MAG
|
[NCBI]
|
0.000170424
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
0.000157868
|
|
|
PIGA
|
[NCBI]
|
0.000156441
|
|
|
GAL3ST1
|
[NCBI]
|
0.000139718
|
|
|
mucolipidosis ii
|
[NCBI]
|
0.00012769
|
|
|
neuraminidase deficiency
|
[NCBI]
|
0.00012175
|
|
|
combined saposin deficiency
|
[NCBI]
|
0.000115357
|
|
|
ceroid storage disease
|
[NCBI]
|
0.000115357
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
0.000106388
|
|
|
RA
|
[NCBI]
|
0.000100682
|
|
|
HSAN2
|
[NCBI]
|
8.74559e-05
|
|
|
PSAP
|
[NCBI]
|
8.54413e-05
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
8.06253e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
7.70119e-05
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
7.70119e-05
|
|
|
gaucher disease, type ii
|
[NCBI]
|
7.70119e-05
|
|
|
blood group, p system
|
[NCBI]
|
6.99356e-05
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
6.76383e-05
|
|
|
TLR4
|
[NCBI]
|
6.61371e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
6.45892e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
6.27702e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
6.19148e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
6.10918e-05
|
|
|
MSD
|
[NCBI]
|
5.36575e-05
|
|
|
A4GALT
|
[NCBI]
|
5.36361e-05
|
|
|
ALD
|
[NCBI]
|
5.28041e-05
|
|
|
AL-A1
|
[NCBI]
|
5.26149e-05
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
5.20113e-05
|
|
|
CD1D
|
[NCBI]
|
4.79598e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
4.3825e-05
|
|
|
fucosidosis
|
[NCBI]
|
3.80842e-05
|
|
|
krabbe disease
|
[NCBI]
|
3.57528e-05
|
|
|
CHST10
|
[NCBI]
|
3.33297e-05
|
|
|
ST3GAL6
|
[NCBI]
|
3.33297e-05
|
|
|
ACHE
|
[NCBI]
|
3.22919e-05
|
|
|
TNF
|
[NCBI]
|
3.13964e-05
|
|
|
GBGT1
|
[NCBI]
|
3.05304e-05
|
|
|
GBA2
|
[NCBI]
|
3.05304e-05
|
|
|
LY96
|
[NCBI]
|
3.05304e-05
|
|
|
LAT
|
[NCBI]
|
2.99531e-05
|
|
|
SLC35A1
|
[NCBI]
|
2.87134e-05
|
|
|
PIGB
|
[NCBI]
|
2.87134e-05
|
|
|
NT5E
|
[NCBI]
|
2.87134e-05
|
|
|
CD1C
|
[NCBI]
|
2.87134e-05
|
|
|
glycolipid transfer protein
|
[NCBI]
|
2.87134e-05
|
|
|
CD1E
|
[NCBI]
|
2.87134e-05
|
|
|
LBP
|
[NCBI]
|
2.8012e-05
|
|
|
HPS
|
[NCBI]
|
2.79504e-05
|
|
|
MAN2A1
|
[NCBI]
|
2.7363e-05
|
|
|
B3GAT1
|
[NCBI]
|
2.7363e-05
|
|
|
GP2
|
[NCBI]
|
2.7363e-05
|
|
|
CD24
|
[NCBI]
|
2.62874e-05
|
|
|
TREH
|
[NCBI]
|
2.62874e-05
|
|
|
B3GALNT1
|
[NCBI]
|
2.53934e-05
|
|
|
BTN1A1
|
[NCBI]
|
2.39599e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
2.37199e-05
|
|
|
PAG1
|
[NCBI]
|
2.23478e-05
|
|
|
CD1A
|
[NCBI]
|
2.19037e-05
|
|
|
SLC17A5
|
[NCBI]
|
2.19037e-05
|
|
|
FOLR1
|
[NCBI]
|
2.1494e-05
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
2.1494e-05
|
|
|
KIF2C
|
[NCBI]
|
2.1494e-05
|
|
|
BL
|
[NCBI]
|
2.09537e-05
|
|
|
CD209
|
[NCBI]
|
2.07592e-05
|
|
|
CNP
|
[NCBI]
|
2.07592e-05
|
|
|
LAMA2
|
[NCBI]
|
2.01144e-05
|
|
|
NGFB
|
[NCBI]
|
2.00114e-05
|
|
|
THY1
|
[NCBI]
|
1.98194e-05
|
|
|
AT
|
[NCBI]
|
1.80929e-05
|
|
|
DDOST
|
[NCBI]
|
1.6679e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.24722e-05
|
|
|
NGFR
|
[NCBI]
|
8.44422e-06
|
|
|
CF
|
[NCBI]
|
7.86758e-06
|
|
|
MCP
|
[NCBI]
|
7.83787e-06
|
|
|
phenylketonuria
|
[NCBI]
|
7.23712e-06
|
|
|
SLE
|
[NCBI]
|
6.96332e-06
|
|
|
PRL
|
[NCBI]
|
5.77179e-06
|
|
|
EGF
|
[NCBI]
|
3.99883e-06
|
|
|
MUC1
|
[NCBI]
|
2.34082e-06
|
|
|
TH
|
[NCBI]
|
1.68291e-06
|
|
|
XDH
|
[NCBI]
|
1.48008e-06
|
|
|
SLC6A3
|
[NCBI]
|
1.4138e-06
|
|
|
LPL
|
[NCBI]
|
1.3533e-06
|
|
|
AHR
|
[NCBI]
|
1.14349e-06
|
|
|
GFAP
|
[NCBI]
|
1.05631e-06
|
|
|
APOB
|
[NCBI]
|
9.93387e-07
|
|
|
MBP
|
[NCBI]
|
9.72731e-07
|
|
|
HGF
|
[NCBI]
|
8.75177e-07
|
|
|
BDNF
|
[NCBI]
|
6.05374e-07
|
|
|
MPO
|
[NCBI]
|
4.15015e-07
|
|
|
ADA
|
[NCBI]
|
4.12432e-07
|
|